Estrogen receptor in malignant melanoma: fact or artefact?
Zava, D.T.; Goldhirsch, A.
European Journal of Cancer and Clinical Oncology 19(8): 1151-1159
1983
ISSN/ISBN: 0277-5379 PMID: 6311560 Document Number: 217063
A model system is presented to explain how tyrosinase, an enzyme unique to pigmented cells such as normal and malignant melanocytes, can oxidize -estradiol.
Document emailed within 1 workday
Related Documents
Gale, E.A. 1985: The dawn phenomenon--fact or artefact? Netherlands Journal of Medicine 28(Suppl 1): 50-52Lau, G. 1995: Pulmonary cartilage embolism: fact or artefact? American Journal of Forensic Medicine and Pathology 16(1): 51-53
Boomsma, F.; in 't Veld, A.J.; Schalekamp, M.A. 1991: Specific binding of catecholamines to plasma proteins: fact or artefact? Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 9(6): S92-S93
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Kotula-Balak, M.; Gancarczyk, M.; Sadowska, J.; Bilinskai, B. 2005: The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males European Journal of Histochemistry: Ejh 49(1): 59-62
Masiuk, M. 2006: Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry Annales Academiae Medicae Stetinensis 52(2): 23-32
Echeverría, O.M.; Thampan, R.V.; Juárez-Chavero, S.; Hernández-Pérez, A.D.; Ortiz, R.; Vázquez-Nin, G.H. 2005: Immunocytochemical study of estrogen receptor activation factor (E-RAF) and the proteins that interact with nuclear estrogen receptor II (nER II) in epithelial endometrial cells, in the presence and in the absence of estradiol European Journal of Histochemistry: Ejh 49(1): 67-74
Shiozawa, T.; Itoh, K.; Horiuchi, A.; Konishi, I.; Fujii, S.; Nikaido, T. 2002: Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma Anticancer Research 22(1a): 139-143
Ebuchi, M. 1987: Estrogen receptor kinetics in benign and malignant diseases of the breast and their clinical implication Nihon Geka Gakkai Zasshi 88(6): 746-754
Steinert, H.; Huch-Böni, R.A.; Böni, R.; Westera, G.; Buck, A. 1995: Dopamine-D2 receptor scintigraphy with 123I-iodobenzofuran in malignant melanoma Nuklearmedizin. Nuclear Medicine 34(4): 146-150
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Fondo, E.Y.; Menendez-Botet, C.J.; Schwartz, M.K.; Whitmore, W.F. 1981: Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report Journal of the National Medical Association 73(3): 261-266
Fischer, E.G.; Ruf, W.; Mueller, B.M. 1995: Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells Cancer Research 55(8): 1629-1632
Takano, N.; Kimura, J.; Okada, H. 1982: Defective estrogen receptor in uteri of rats treated neonatally with a high dose of estrogen Nihon Sanka Fujinka Gakkai Zasshi 34(3): 391-395